The present invention relates to methods of vaccinating subjects receiving immune modulating therapy, such as soluble CTLA4 molecules, for treatment of immune system diseases mediated by T-cell interactions with B7-positive cells including, but not limited to, autoimmune diseases, immunoproliferative diseases, and immune disorders associated with graft transplantation.

 
Web www.patentalert.com

< CAPSAICINOID DECONTAMINATION COMPOSITIONS AND METHODS OF USE

> METHODS AND FORMULATIONS FOR TREATING CHRONIC LIVER DISEASE

> COMPOUNDS

~ 00515